Nuvilex Release: Therapeutic Antibody Producing Cells Encapsulated Using Cell-in-a-Box® Encapsulation Technology Proven Effective for Targeted Treatment of Various Diseases
SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions through acquisition of SG Austria assets, realizes the important role for Cell-in-a-Box® technology and aims to bring to light its use in the production of therapeutic antibodies for clinically important diseases.